| GCLSX | VIVAX | GCLSX / VIVAX | |
| Total Expense Ratio | 1.06 | 0.17 | 624% |
| Annual Report Gross Expense Ratio | 1.13 | 0.17 | 665% |
| Fund Existence | 27 years | 34 years | - |
| Gain YTD | 12.621 | 13.350 | 95% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 719M | 245B | 0% |
| Annual Yield % from dividends | 0.66 | 1.76 | 38% |
| Returns for 1 year | 20.16 | 25.00 | 81% |
| Returns for 3 years | 29.42 | 56.38 | 52% |
| Returns for 5 years | 15.40 | 59.70 | 26% |
| Returns for 10 years | 82.01 | 163.77 | 50% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MDFGX | 38.77 | N/A | N/A |
| BlackRock Capital Appreciation Inv A | |||
| MDDLX | 9.46 | N/A | N/A |
| MassMutual Diversified Value Adm | |||
| VISVX | 57.18 | N/A | N/A |
| Vanguard Small Cap Value Index Inv | |||
| TQTIX | 19.81 | N/A | N/A |
| AMG TimesSquare International SmallCap I | |||
| AVENX | 18.81 | N/A | N/A |
| Avantis® Emerging Markets Equity G | |||